FDA Flouting Court On Orphan Drug Exclusivity, Suit Says
The U.S. Food and Drug Administration is flouting a recent court ruling and federal law by refusing to grant orphan drug exclusivity for chemotherapy infusion Bendeka, according to a complaint filed...To view the full article, register now.
Already a subscriber? Click here to view full article